Compare AMH & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMH | HOLX |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 16.6B |
| IPO Year | 2013 | 1990 |
| Metric | AMH | HOLX |
|---|---|---|
| Price | $30.83 | $74.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 15 |
| Target Price | $38.20 | ★ $79.64 |
| AVG Volume (30 Days) | 2.5M | ★ 3.0M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | ★ 23.05 | N/A |
| EPS | 1.18 | ★ 2.49 |
| Revenue | $1,831,836,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $8.29 | $6.69 |
| Revenue Next Year | $4.11 | $5.74 |
| P/E Ratio | ★ $26.14 | $30.11 |
| Revenue Growth | ★ 7.71 | 1.74 |
| 52 Week Low | $30.63 | $51.90 |
| 52 Week High | $39.49 | $80.31 |
| Indicator | AMH | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 34.23 | 67.93 |
| Support Level | $31.80 | $74.55 |
| Resistance Level | $32.73 | $75.12 |
| Average True Range (ATR) | 0.49 | 0.28 |
| MACD | -0.09 | -0.14 |
| Stochastic Oscillator | 9.31 | 78.92 |
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.